Mammography Workstation Market Report 2026

The mammography workstation market size has grown strongly in recent years. It will grow from $1.13 billion in 2025 to $1.24 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to increasing adoption of digital mammography systems, growing demand for early breast cancer screening, rising shift from film based imaging to softcopy reading, increasing deployment of mammography workstations in hospitals, growing use of breast imaging reporting and data system (BI-RADS).

The mammography workstation market size is expected to see strong growth in the next few years. It will grow to $1.74 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to growing adoption of three dimensional breast tomosynthesis workstations, increasing integration of multimodality breast imaging, rising demand for advanced clinical review and diagnostic screening tools, expansion of government led breast cancer screening programs, increasing preference for workstation software upgrades and automation. Major trends in the forecast period include technology advancements in artificial intelligence assisted breast image analysis, innovations in high resolution five megapixel and eight megapixel displays, developments in multimodality diagnostic imaging workstations, research and developments in synthetic two dimensional imaging and breast tomosynthesis, advancements in workflow automation and smart hanging protocols.

The increasing mammography exam volumes are expected to propel the growth of the mammography workstation market going forward. Increasing mammography exam volumes refer to the rising number of breast imaging procedures performed annually, driven by aging populations and expanded public health initiatives focused on early breast cancer detection. Advancements in digital imaging technologies, including 3D digital breast tomosynthesis, are contributing to higher exam volumes and greater image complexity, creating a need for high-performance tools that can efficiently manage and interpret large datasets. Mammography workstations address this demand by enabling streamlined diagnostic workflows through advanced visualization software, high-resolution displays, and artificial intelligence-based decision support, helping radiologists detect abnormalities with greater speed and precision. For instance, in 2023, according to the United States Food and Drug Administration (FDA), a US-based federal agency responsible for protecting public health, there were 8,823 total certified mammography facilities with 25,098 accredited units as of August 1, 2023, compared to 8,790 certified facilities as of October 1, 2022. Therefore, increasing mammography exam volumes are driving the growth of the mammography workstation market.

Major companies operating in the mammography workstation market are concentrating on developing advanced solutions, such as deep learning reconstruction software, to improve efficiency, strengthen diagnostic confidence, and minimize manual effort and image interpretation time. Deep learning reconstruction software involves sophisticated algorithms that apply artificial intelligence to process and reconstruct mammography images, enhancing image quality and detail. For example, in November 2025, GE HealthCare Technologies Inc., a US-based medical technology company, received U.S. Food and Drug Administration (FDA) Premarket Authorization for Pristina Recon DL, a deep learning-based 3D mammography image reconstruction technology. This AI-driven solution uses two sequential deep learning models to distinguish clinically relevant signals from noise, generating high-quality 3D volumes with fewer artifacts and clearer synthesized 2D images. According to the company, it is the first mammography technology to integrate deep learning with iterative reconstruction for digital breast tomosynthesis (DBT) without increasing radiation exposure. The system features zero-click acquisition and personalized protocols, allowing smooth workflow integration and a patient-focused design, thereby enhancing operational efficiency for breast imaging centers.

In May 2024, Lunit Inc., a South Korea-based medical AI company focused on cancer diagnostics and therapeutics, acquired Volpara Health Technologies Ltd. for approximately AUD 292 million (USD 193 million). Through this acquisition, Lunit Inc. aimed to broaden its AI-powered cancer care portfolio and reinforce its position in the breast cancer screening market by leveraging Volpara’s large database of more than 100 million high-quality mammography images and its strong presence in the US market. Volpara Health Technologies Ltd. is a New Zealand-based company that specializes in the development of advanced mammography workstation solutions.

Major companies operating in the mammography workstation market are Siemens Healthineers AG, Fujifilm Holdings Corporation, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Hologic Inc., Agfa-Gevaert N.V., Barco N.V., Carestream Health Inc., EIZO Corporation, Konica Minolta Business Solutions India Pvt. Ltd., Sectra AB, Candelis Corporation, Planmed Inc., iCAD Inc., Medequal Systems & Supplies Inc., Aycan Medical Systems LLC, Metaltronica S.p.A., Three Palm Software Inc., IMS Giotto S.p.A, Medi-Future Inc.

North America was the largest region in the Mammography Workstation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammography workstation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mammography workstation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the mammography workstations market by increasing costs of imported high-resolution monitors, graphic processing units, storage hardware, and specialized imaging components. healthcare providers in north america and europe are most affected due to reliance on imported advanced workstation hardware, while asia-pacific faces higher costs for workstation manufacturing and deployment. these tariffs are raising capital investment requirements and slowing workstation upgrade cycles. however, they are also encouraging localized assembly, regional supplier partnerships, and increased adoption of software-centric and cloud-based mammography workstation solutions.

Mammography workstations are specialized medical imaging systems designed for the display, analysis, and interpretation of digital mammography images. They are equipped with high-resolution monitors and advanced image-processing tools that enable precise visualization of breast tissue details. These workstations support radiologists in the early detection, diagnosis, and monitoring of breast cancer by improving image clarity, enhancing diagnostic confidence, streamlining workflow efficiency, and supporting accurate clinical decision-making in breast imaging.

The primary product types of mammography workstations are multimodality workstations and standalone workstations. Multimodality workstations support multiple breast imaging techniques within one integrated platform for comprehensive assessment. Modalities include 2D mammography, 3D mammography, digital mammography, and others, deployed through on-premises or cloud-based systems, and used in diagnostic screening, clinical review, and advanced imaging across hospitals, diagnostic centers, and specialty clinics.

The mammography workstations market consists of revenues earned by entities by providing services such as image processing and visualization, computer-aided detection and diagnosis (CAD), workflow management, diagnostic reporting, system integration, software upgrades, maintenance, and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The mammography workstations market also includes sales of advanced diagnostic software solutions, high-resolution medical imaging monitors, computer-aided detection and diagnosis (CAD) systems, and integrated hardware-software platforms. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.